Torafugu Tech

Improving Health

With Wearables And Ai

At Torafugu tech, our aim is to help individuals with pre-existing conditions reduce insurance costs by managing their disease.

Translate lifestyle data

into relevant actionable information.

We are developing software and algorithms and engaging in R&D on Artificial Intelligence (AI) for use in term life insurance. Our algorithms look to process, aggregate and sort data in real-time providing on-demand processing of multiple streams of data.

Using members’ existing digital footprint, including data from their existing app usage, social media, banking transactions and family history we have been able to calculate new predictive disease risk scores with 99.2% accuracy. Taking lifestyle data alone we can monitor how well members manage their disease and dynamically adjust their cost of insurance on a monthly basis.

The Challenge

The Problem We’re Trying

To Solve And Why

We are building a personalised life insurance product to help individuals with pre-existing health conditions reduce premiums by managing their disease. Our initial focus is lifestyle related diseases, often people who suffer from those find it difficult to secure term life insurance.

One of our areas of focus is Type-2 Diabetes. Insurers today see diabetics all the same, one homogeneous high risk group. However, some diabetics, manage their condition much better than others. Currently, insurers do not acknowledge this.

The only time life insurers collect data about their customers is at the point of sale so they do not have insight into how someone’s health is changing over the course of the policy. Yet lifestyle intervention matters, type-2 diabetes can be reversed.

Even small changes to diabetes measures can result in significant increases in life expectancy.

Solution

Help Members Live Healthier And Longer Lives With Lower Insurance Costs.

Purchasing life insurance is time consuming, onerous and cumbersome. Prospective customers are left frustrated by a frequently long application process. Information is often inaccurate leaving insurers with the headache of identifying a reliable ‘source’ of truth and members suffering with pay-out anxiety.

Personalisation is also increasingly important in life insurance as customers look towards a better experience. Particularly digitally enabled customers who demand more from their financial services providers. Our app-based solution provides fast on boarding and the tools to translate lifestyle measures into actionable information to help members live healthier lives.

Our lifestyle coach app utilises behaviour nudges, rewards and gamification which can help with personalisation. And it works, not least of all because members are motivated.

There is good evidence that in low activity groups, as much as 45% increase in activity can be maintained for at least 3 months. A promising start and our tools can further enhance members health and reduce insurance risk in the long term.

Innovation

Machine Learning Excellence.

Our algorithms look to processes, aggregate and sort data in real time providing on-demand processing of multiple streams of data. Ultimately, we envision our new engines will be used for a number of diseases including cardiovascular disease, type-2 diabetes, lung cancer, respiratory disease and more.

Our processes allow real-time tracking of complex data and introducing machine learning excellence for use in healthcare. We aim to process data in the best possible way to drive health outcomes.

The processing of relevant health information should build a comprehensive health risks profile that is customised to the individual. With the epigenetic and personalised medicine revolution currently ongoing in healthcare, vast amounts of data will be generated and our platform will allow it to be organised in a smart yet unique way.

Meet Our Team

Savvas Neophytou

Chief Executive Officer

Savvas had previously been one of the original team and ex-CEO of Europe’s largest telemedicine business Now Healthcare Group with >1m users, Savvas is a serial entrepreneur and investor through Deepbridge Capital. Prior to his time as an entrepreneur, he was a corporate financier and ECM banker at JP Morgan, Bear Stearns, Cantor Fitzgerald and Panmure Gordon. Holds B.Sc. Manchester and PhD Nottingham.

Tassos Anastasiou

Chief Strategy and Growth Officer

A trained actuary, Tassos started his career at Deloitte and then Ernst and Young in London focusing on Merger and Acquisitions. Afterwards he moved to the Emerging Markets business unit of Royal & Sun Alliance where he held positions of the chief actuary, CFO and ultimately CEO. In 2016, after his exit from RSA he turned his attention to InsurTech and FinTech where he operates as founder, advisor or business angel investor. Some of the ventures he is involved with are around cyber risk scoring, on-demand insurance for the sharing economy, utilisation of telematics in claims management, development of an agile insurance platform that supports start ups and AI, machine learning for AML/KYC and transaction monitoring. Tassos is a Fellow of the Institute and Faculty of Actuaries (UK) and holds an eMBA from INSEAD and BSc (Hons) degree in actuarial science from London School of Economics and Political Science.

Ioannis Ioannou

Chief Operating Officer

Ioannis has had a rich and varied career within the insurance industry, starting at Tillinghast, the actuarial consultancy, and taking up senior roles in both global corporations, such as Swiss Re, and smaller niche players such as Pension Insurance Corporation and Just Retirement. Ioannis’ most recent role was Director of Capital Management at Prudential Plc, responsible for optimising the company’s global capital position and stabilising its balance sheet. Ioannis also has a strong background in public capital markets and investment banking from his time as Director at Lehman Brothers and BNP Paribas.

Manisha Bhatnagar

Medical Director

Still a practicing doctor working within NHS with over 20 year experience, Dr. Manisha Bhatnagar MBChB is a pioneer in the telemedicine space as she had previously been one of the first doctors on the Now Healthcare Group platform Dr Now.

Sorcha Moore

UX/UI Product and Service Designer

Sorcha is an experienced UX/UI product and service designer with a strong entrepreneurial foundation. She started her career in the gaming industry as a UX designer at Full Tilt Poker and also worked in a similar role at PokerStars. Most recently she has consulted as a UX designer for UK government’s Education and Skills Funding agency. She is also a proud member of NDRC female founders and holds a degree in Science multimedia from DCU in Ireland.

Dr Anastasia Sylaidi

Data Science Consultant

Anastasia is a postdoctoral researcher at Imperial College London an advisor to RH Capital and a retained AI consultant of Torafugu Tech. She holds a masters degree in Computational Neuroscience from the Swiss Federal Institute of Technology (ETH), Zurich. Anastasia’s PhD was on Systems and Computational Neuroscience at the Bioengineering Department of Imperial College London. Her research is focused on elucidating mechanisms of human sensorimotor control and learning at the systems and computational level. She is recognized as a global thought leader in the use of artificial learning in the study of biological systems and disease.

FAQ’s

Read some of our most frequently asked questions from our partners and users.

Get In Touch

We would love to hear from you. Fill out our contact form to get the ball rolling.

In The Press

March 19, 2018 in Press & Media

Torafugu tech wins Startupbootcamp place

Torafugu tech wins place into the Startupbootcamp digital health accelerator in Berlin. Click here to find out more...
Read More
March 19, 2018 in Press & Media

Demo Day Presentation

Impressive demo day presentation by Torafugu tech is received well by a full house who agree people with pre-existing medical conditions are underserved by insurers. Click here to find out…
Read More

Our Blog

June 11, 2018 in Blog

What is type 2 diabetes?

Type 2 Diabetes is a chronic disease in which the blood sugar or glucose level becomes abnormally high (hyperglycaemia), due to a loss in insulin secretion and/or function. Normally, the…
Read More